nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—ADRA2A—Amitriptyline—migraine	0.214	1	CbGbCtD
Brimonidine—ADRA2C—Amine ligand-binding receptors—HTR2A—migraine	0.00142	0.00687	CbGpPWpGaD
Brimonidine—ADRA2A—Monoamine GPCRs—HTR2A—migraine	0.00137	0.00664	CbGpPWpGaD
Brimonidine—ADRA2A—Amine ligand-binding receptors—HTR2A—migraine	0.00116	0.00558	CbGpPWpGaD
Brimonidine—ADRA2B—G alpha (i) signalling events—HTR1D—migraine	0.00109	0.00527	CbGpPWpGaD
Brimonidine—ADRA2C—G alpha (i) signalling events—HTR1D—migraine	0.00102	0.00492	CbGpPWpGaD
Brimonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.00101	0.00489	CbGpPWpGaD
Brimonidine—Lethargy—Topiramate—migraine	0.000978	0.00169	CcSEcCtD
Brimonidine—Dry mouth—Verapamil—migraine	0.000972	0.00168	CcSEcCtD
Brimonidine—Bradycardia—Valproic Acid—migraine	0.000968	0.00167	CcSEcCtD
Brimonidine—Osteoarthritis—Topiramate—migraine	0.000959	0.00166	CcSEcCtD
Brimonidine—Rhinitis—Valproic Acid—migraine	0.000953	0.00165	CcSEcCtD
Brimonidine—Oedema—Verapamil—migraine	0.000953	0.00165	CcSEcCtD
Brimonidine—Bronchitis—Gabapentin—migraine	0.000947	0.00164	CcSEcCtD
Brimonidine—Infection—Verapamil—migraine	0.000947	0.00164	CcSEcCtD
Brimonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000945	0.00457	CbGpPWpGaD
Brimonidine—Pharyngitis—Valproic Acid—migraine	0.000944	0.00163	CcSEcCtD
Brimonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000941	0.00455	CbGpPWpGaD
Brimonidine—Depression—Timolol—migraine	0.00094	0.00163	CcSEcCtD
Brimonidine—Shock—Verapamil—migraine	0.000938	0.00162	CcSEcCtD
Brimonidine—Insomnia—Propranolol—migraine	0.000937	0.00162	CcSEcCtD
Brimonidine—Paraesthesia—Propranolol—migraine	0.00093	0.00161	CcSEcCtD
Brimonidine—Tachycardia—Verapamil—migraine	0.00093	0.00161	CcSEcCtD
Brimonidine—Face oedema—Topiramate—migraine	0.000926	0.0016	CcSEcCtD
Brimonidine—Dyspnoea—Propranolol—migraine	0.000924	0.0016	CcSEcCtD
Brimonidine—Somnolence—Propranolol—migraine	0.000921	0.00159	CcSEcCtD
Brimonidine—Conjunctivitis—Timolol—migraine	0.000917	0.00158	CcSEcCtD
Brimonidine—Visual impairment—Valproic Acid—migraine	0.000917	0.00158	CcSEcCtD
Brimonidine—Asthenia—Amitriptyline—migraine	0.000913	0.00158	CcSEcCtD
Brimonidine—Dyspepsia—Propranolol—migraine	0.000912	0.00158	CcSEcCtD
Brimonidine—ADRA2B—GPCR ligand binding—CALCRL—migraine	0.000909	0.00439	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—RAMP1—migraine	0.000909	0.00439	CbGpPWpGaD
Brimonidine—Pruritus—Amitriptyline—migraine	0.0009	0.00156	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Propranolol—migraine	0.000894	0.00155	CcSEcCtD
Brimonidine—Fatigue—Propranolol—migraine	0.000893	0.00154	CcSEcCtD
Brimonidine—Hypotension—Verapamil—migraine	0.00089	0.00154	CcSEcCtD
Brimonidine—Eye disorder—Valproic Acid—migraine	0.000889	0.00154	CcSEcCtD
Brimonidine—Pain—Propranolol—migraine	0.000886	0.00153	CcSEcCtD
Brimonidine—Sinusitis—Timolol—migraine	0.000885	0.00153	CcSEcCtD
Brimonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000879	0.00425	CbGpPWpGaD
Brimonidine—Drowsiness—Gabapentin—migraine	0.000878	0.00152	CcSEcCtD
Brimonidine—Depression—Gabapentin—migraine	0.000876	0.00151	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Verapamil—migraine	0.000868	0.0015	CcSEcCtD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000867	0.00419	CbGpPWpGaD
Brimonidine—Angiopathy—Valproic Acid—migraine	0.000863	0.00149	CcSEcCtD
Brimonidine—Insomnia—Verapamil—migraine	0.000862	0.00149	CcSEcCtD
Brimonidine—Bradycardia—Timolol—migraine	0.000862	0.00149	CcSEcCtD
Brimonidine—Immune system disorder—Valproic Acid—migraine	0.000859	0.00148	CcSEcCtD
Brimonidine—Nasopharyngitis—Topiramate—migraine	0.000857	0.00148	CcSEcCtD
Brimonidine—Mediastinal disorder—Valproic Acid—migraine	0.000857	0.00148	CcSEcCtD
Brimonidine—Paraesthesia—Verapamil—migraine	0.000856	0.00148	CcSEcCtD
Brimonidine—Conjunctivitis—Gabapentin—migraine	0.000854	0.00148	CcSEcCtD
Brimonidine—Arrhythmia—Valproic Acid—migraine	0.00085	0.00147	CcSEcCtD
Brimonidine—Dyspnoea—Verapamil—migraine	0.00085	0.00147	CcSEcCtD
Brimonidine—ADRA2C—GPCR ligand binding—RAMP1—migraine	0.000849	0.0041	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—CALCRL—migraine	0.000849	0.0041	CbGpPWpGaD
Brimonidine—Rhinitis—Timolol—migraine	0.000849	0.00147	CcSEcCtD
Brimonidine—Somnolence—Verapamil—migraine	0.000847	0.00146	CcSEcCtD
Brimonidine—Dizziness—Amitriptyline—migraine	0.000841	0.00145	CcSEcCtD
Brimonidine—Dyspepsia—Verapamil—migraine	0.000839	0.00145	CcSEcCtD
Brimonidine—Mental disorder—Valproic Acid—migraine	0.000833	0.00144	CcSEcCtD
Brimonidine—ADRA2A—G alpha (i) signalling events—HTR1D—migraine	0.000828	0.004	CbGpPWpGaD
Brimonidine—Sinusitis—Gabapentin—migraine	0.000824	0.00142	CcSEcCtD
Brimonidine—Fatigue—Verapamil—migraine	0.000822	0.00142	CcSEcCtD
Brimonidine—Visual impairment—Timolol—migraine	0.000816	0.00141	CcSEcCtD
Brimonidine—Pain—Verapamil—migraine	0.000815	0.00141	CcSEcCtD
Brimonidine—Dysgeusia—Valproic Acid—migraine	0.000811	0.0014	CcSEcCtD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00081	0.00391	CbGpPWpGaD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000806	0.00389	CbGpPWpGaD
Brimonidine—Bradycardia—Gabapentin—migraine	0.000803	0.00139	CcSEcCtD
Brimonidine—Rash—Amitriptyline—migraine	0.000802	0.00139	CcSEcCtD
Brimonidine—Dermatitis—Amitriptyline—migraine	0.000802	0.00139	CcSEcCtD
Brimonidine—Headache—Amitriptyline—migraine	0.000797	0.00138	CcSEcCtD
Brimonidine—Bronchitis—Topiramate—migraine	0.000797	0.00138	CcSEcCtD
Brimonidine—Eye disorder—Timolol—migraine	0.000791	0.00137	CcSEcCtD
Brimonidine—Rhinitis—Gabapentin—migraine	0.00079	0.00137	CcSEcCtD
Brimonidine—Cardiac disorder—Timolol—migraine	0.000786	0.00136	CcSEcCtD
Brimonidine—Pharyngitis—Gabapentin—migraine	0.000783	0.00135	CcSEcCtD
Brimonidine—Vision blurred—Valproic Acid—migraine	0.00078	0.00135	CcSEcCtD
Brimonidine—Angiopathy—Timolol—migraine	0.000768	0.00133	CcSEcCtD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000768	0.00371	CbGpPWpGaD
Brimonidine—Immune system disorder—Timolol—migraine	0.000765	0.00132	CcSEcCtD
Brimonidine—Hypersensitivity—Propranolol—migraine	0.000763	0.00132	CcSEcCtD
Brimonidine—Mediastinal disorder—Timolol—migraine	0.000763	0.00132	CcSEcCtD
Brimonidine—Visual impairment—Gabapentin—migraine	0.00076	0.00131	CcSEcCtD
Brimonidine—Arrhythmia—Timolol—migraine	0.000756	0.00131	CcSEcCtD
Brimonidine—Nausea—Amitriptyline—migraine	0.000756	0.00131	CcSEcCtD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000753	0.00364	CbGpPWpGaD
Brimonidine—Asthenia—Propranolol—migraine	0.000743	0.00128	CcSEcCtD
Brimonidine—Mental disorder—Timolol—migraine	0.000742	0.00128	CcSEcCtD
Brimonidine—Erythema—Timolol—migraine	0.000737	0.00127	CcSEcCtD
Brimonidine—Eye disorder—Gabapentin—migraine	0.000737	0.00127	CcSEcCtD
Brimonidine—Depression—Topiramate—migraine	0.000737	0.00127	CcSEcCtD
Brimonidine—Cardiac disorder—Gabapentin—migraine	0.000732	0.00126	CcSEcCtD
Brimonidine—Palpitations—Valproic Acid—migraine	0.000732	0.00126	CcSEcCtD
Brimonidine—Cough—Valproic Acid—migraine	0.000722	0.00125	CcSEcCtD
Brimonidine—Dysgeusia—Timolol—migraine	0.000722	0.00125	CcSEcCtD
Brimonidine—Conjunctivitis—Topiramate—migraine	0.000718	0.00124	CcSEcCtD
Brimonidine—Hypertension—Valproic Acid—migraine	0.000715	0.00124	CcSEcCtD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000714	0.00345	CbGpPWpGaD
Brimonidine—Immune system disorder—Gabapentin—migraine	0.000712	0.00123	CcSEcCtD
Brimonidine—Mediastinal disorder—Gabapentin—migraine	0.000711	0.00123	CcSEcCtD
Brimonidine—Chest pain—Valproic Acid—migraine	0.000705	0.00122	CcSEcCtD
Brimonidine—Arthralgia—Valproic Acid—migraine	0.000705	0.00122	CcSEcCtD
Brimonidine—Myalgia—Valproic Acid—migraine	0.000705	0.00122	CcSEcCtD
Brimonidine—Anxiety—Valproic Acid—migraine	0.000702	0.00121	CcSEcCtD
Brimonidine—Hypersensitivity—Verapamil—migraine	0.000702	0.00121	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.0007	0.00121	CcSEcCtD
Brimonidine—Discomfort—Valproic Acid—migraine	0.000696	0.0012	CcSEcCtD
Brimonidine—Vision blurred—Timolol—migraine	0.000695	0.0012	CcSEcCtD
Brimonidine—Sinusitis—Topiramate—migraine	0.000693	0.0012	CcSEcCtD
Brimonidine—Mental disorder—Gabapentin—migraine	0.000691	0.00119	CcSEcCtD
Brimonidine—ADRA2A—GPCR ligand binding—CALCRL—migraine	0.00069	0.00333	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—RAMP1—migraine	0.00069	0.00333	CbGpPWpGaD
Brimonidine—Dry mouth—Valproic Acid—migraine	0.000689	0.00119	CcSEcCtD
Brimonidine—Erythema—Gabapentin—migraine	0.000686	0.00119	CcSEcCtD
Brimonidine—Dizziness—Propranolol—migraine	0.000685	0.00118	CcSEcCtD
Brimonidine—Asthenia—Verapamil—migraine	0.000684	0.00118	CcSEcCtD
Brimonidine—Oedema—Valproic Acid—migraine	0.000676	0.00117	CcSEcCtD
Brimonidine—Bradycardia—Topiramate—migraine	0.000675	0.00117	CcSEcCtD
Brimonidine—Pruritus—Verapamil—migraine	0.000674	0.00117	CcSEcCtD
Brimonidine—Dysgeusia—Gabapentin—migraine	0.000672	0.00116	CcSEcCtD
Brimonidine—Infection—Valproic Acid—migraine	0.000671	0.00116	CcSEcCtD
Brimonidine—Rhinitis—Topiramate—migraine	0.000665	0.00115	CcSEcCtD
Brimonidine—Nervous system disorder—Valproic Acid—migraine	0.000663	0.00115	CcSEcCtD
Brimonidine—Syncope—Timolol—migraine	0.000661	0.00114	CcSEcCtD
Brimonidine—ADRA2B—G alpha (i) signalling events—HTR1B—migraine	0.000661	0.00319	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—HTR1D—migraine	0.00066	0.00319	CbGpPWpGaD
Brimonidine—Tachycardia—Valproic Acid—migraine	0.000659	0.00114	CcSEcCtD
Brimonidine—Pharyngitis—Topiramate—migraine	0.000658	0.00114	CcSEcCtD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000658	0.00318	CbGpPWpGaD
Brimonidine—Skin disorder—Valproic Acid—migraine	0.000656	0.00113	CcSEcCtD
Brimonidine—Rash—Propranolol—migraine	0.000653	0.00113	CcSEcCtD
Brimonidine—Dermatitis—Propranolol—migraine	0.000653	0.00113	CcSEcCtD
Brimonidine—Palpitations—Timolol—migraine	0.000651	0.00113	CcSEcCtD
Brimonidine—Loss of consciousness—Timolol—migraine	0.000648	0.00112	CcSEcCtD
Brimonidine—Vision blurred—Gabapentin—migraine	0.000647	0.00112	CcSEcCtD
Brimonidine—Cough—Timolol—migraine	0.000643	0.00111	CcSEcCtD
Brimonidine—Visual impairment—Topiramate—migraine	0.000639	0.0011	CcSEcCtD
Brimonidine—Hypertension—Timolol—migraine	0.000636	0.0011	CcSEcCtD
Brimonidine—ADRA2B—G alpha (i) signalling events—HTR1A—migraine	0.000636	0.00307	CbGpPWpGaD
Brimonidine—Hypotension—Valproic Acid—migraine	0.000631	0.00109	CcSEcCtD
Brimonidine—Dizziness—Verapamil—migraine	0.00063	0.00109	CcSEcCtD
Brimonidine—Arthralgia—Timolol—migraine	0.000627	0.00108	CcSEcCtD
Brimonidine—Myalgia—Timolol—migraine	0.000627	0.00108	CcSEcCtD
Brimonidine—Chest pain—Timolol—migraine	0.000627	0.00108	CcSEcCtD
Brimonidine—Anxiety—Timolol—migraine	0.000625	0.00108	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000623	0.00108	CcSEcCtD
Brimonidine—Discomfort—Timolol—migraine	0.00062	0.00107	CcSEcCtD
Brimonidine—Eye disorder—Topiramate—migraine	0.00062	0.00107	CcSEcCtD
Brimonidine—ADRA2C—G alpha (i) signalling events—HTR1B—migraine	0.000617	0.00298	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—HTR1D—migraine	0.000617	0.00298	CbGpPWpGaD
Brimonidine—Musculoskeletal discomfort—Valproic Acid—migraine	0.000616	0.00106	CcSEcCtD
Brimonidine—Cardiac disorder—Topiramate—migraine	0.000616	0.00106	CcSEcCtD
Brimonidine—Flushing—Topiramate—migraine	0.000616	0.00106	CcSEcCtD
Brimonidine—Syncope—Gabapentin—migraine	0.000615	0.00106	CcSEcCtD
Brimonidine—Nausea—Propranolol—migraine	0.000615	0.00106	CcSEcCtD
Brimonidine—ADRA2B—GPCR ligand binding—HTR2B—migraine	0.000614	0.00297	CbGpPWpGaD
Brimonidine—Dry mouth—Timolol—migraine	0.000614	0.00106	CcSEcCtD
Brimonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000613	0.00296	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000612	0.00295	CbGpPWpGaD
Brimonidine—Insomnia—Valproic Acid—migraine	0.000611	0.00106	CcSEcCtD
Brimonidine—Paraesthesia—Valproic Acid—migraine	0.000607	0.00105	CcSEcCtD
Brimonidine—Palpitations—Gabapentin—migraine	0.000607	0.00105	CcSEcCtD
Brimonidine—Loss of consciousness—Gabapentin—migraine	0.000603	0.00104	CcSEcCtD
Brimonidine—Dyspnoea—Valproic Acid—migraine	0.000602	0.00104	CcSEcCtD
Brimonidine—Angiopathy—Topiramate—migraine	0.000602	0.00104	CcSEcCtD
Brimonidine—Oedema—Timolol—migraine	0.000602	0.00104	CcSEcCtD
Brimonidine—Rash—Verapamil—migraine	0.000601	0.00104	CcSEcCtD
Brimonidine—Somnolence—Valproic Acid—migraine	0.000601	0.00104	CcSEcCtD
Brimonidine—Dermatitis—Verapamil—migraine	0.0006	0.00104	CcSEcCtD
Brimonidine—Immune system disorder—Topiramate—migraine	0.000599	0.00104	CcSEcCtD
Brimonidine—Cough—Gabapentin—migraine	0.000599	0.00104	CcSEcCtD
Brimonidine—Mediastinal disorder—Topiramate—migraine	0.000598	0.00103	CcSEcCtD
Brimonidine—Infection—Timolol—migraine	0.000598	0.00103	CcSEcCtD
Brimonidine—Headache—Verapamil—migraine	0.000597	0.00103	CcSEcCtD
Brimonidine—Dyspepsia—Valproic Acid—migraine	0.000595	0.00103	CcSEcCtD
Brimonidine—ADRA2C—G alpha (i) signalling events—HTR1A—migraine	0.000594	0.00287	CbGpPWpGaD
Brimonidine—Hypertension—Gabapentin—migraine	0.000593	0.00102	CcSEcCtD
Brimonidine—Shock—Timolol—migraine	0.000592	0.00102	CcSEcCtD
Brimonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00059	0.00285	CbGpPWpGaD
Brimonidine—Nervous system disorder—Timolol—migraine	0.00059	0.00102	CcSEcCtD
Brimonidine—Chest pain—Gabapentin—migraine	0.000584	0.00101	CcSEcCtD
Brimonidine—Arthralgia—Gabapentin—migraine	0.000584	0.00101	CcSEcCtD
Brimonidine—Myalgia—Gabapentin—migraine	0.000584	0.00101	CcSEcCtD
Brimonidine—Skin disorder—Timolol—migraine	0.000584	0.00101	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Valproic Acid—migraine	0.000583	0.00101	CcSEcCtD
Brimonidine—Fatigue—Valproic Acid—migraine	0.000583	0.00101	CcSEcCtD
Brimonidine—Anxiety—Gabapentin—migraine	0.000582	0.00101	CcSEcCtD
Brimonidine—Mental disorder—Topiramate—migraine	0.000581	0.001	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.00058	0.001	CcSEcCtD
Brimonidine—Pain—Valproic Acid—migraine	0.000578	0.000999	CcSEcCtD
Brimonidine—Erythema—Topiramate—migraine	0.000577	0.000998	CcSEcCtD
Brimonidine—Discomfort—Gabapentin—migraine	0.000577	0.000998	CcSEcCtD
Brimonidine—ADRA2C—GPCR ligand binding—HTR2B—migraine	0.000573	0.00277	CbGpPWpGaD
Brimonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000573	0.00277	CbGpPWpGaD
Brimonidine—Dry mouth—Gabapentin—migraine	0.000571	0.000988	CcSEcCtD
Brimonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00057	0.00275	CbGpPWpGaD
Brimonidine—Nausea—Verapamil—migraine	0.000566	0.000978	CcSEcCtD
Brimonidine—Dysgeusia—Topiramate—migraine	0.000565	0.000977	CcSEcCtD
Brimonidine—Hypotension—Timolol—migraine	0.000562	0.000971	CcSEcCtD
Brimonidine—Oedema—Gabapentin—migraine	0.00056	0.000968	CcSEcCtD
Brimonidine—Infection—Gabapentin—migraine	0.000556	0.000962	CcSEcCtD
Brimonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000555	0.00268	CbGpPWpGaD
Brimonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000551	0.00266	CbGpPWpGaD
Brimonidine—Shock—Gabapentin—migraine	0.000551	0.000953	CcSEcCtD
Brimonidine—Nervous system disorder—Gabapentin—migraine	0.000549	0.000949	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Timolol—migraine	0.000548	0.000947	CcSEcCtD
Brimonidine—Tachycardia—Gabapentin—migraine	0.000547	0.000945	CcSEcCtD
Brimonidine—Vision blurred—Topiramate—migraine	0.000544	0.000941	CcSEcCtD
Brimonidine—Skin disorder—Gabapentin—migraine	0.000544	0.00094	CcSEcCtD
Brimonidine—Insomnia—Timolol—migraine	0.000544	0.00094	CcSEcCtD
Brimonidine—Paraesthesia—Timolol—migraine	0.00054	0.000934	CcSEcCtD
Brimonidine—Dyspnoea—Timolol—migraine	0.000536	0.000927	CcSEcCtD
Brimonidine—AOX1—Metabolism—CACNA1A—migraine	0.000535	0.00258	CbGpPWpGaD
Brimonidine—Somnolence—Timolol—migraine	0.000535	0.000924	CcSEcCtD
Brimonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000533	0.00257	CbGpPWpGaD
Brimonidine—Dyspepsia—Timolol—migraine	0.000529	0.000915	CcSEcCtD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000525	0.00254	CbGpPWpGaD
Brimonidine—Hypotension—Gabapentin—migraine	0.000523	0.000905	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Timolol—migraine	0.000519	0.000898	CcSEcCtD
Brimonidine—Fatigue—Timolol—migraine	0.000519	0.000896	CcSEcCtD
Brimonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000518	0.0025	CbGpPWpGaD
Brimonidine—Syncope—Topiramate—migraine	0.000518	0.000895	CcSEcCtD
Brimonidine—Pain—Timolol—migraine	0.000514	0.000889	CcSEcCtD
Brimonidine—ADRA2B—GPCR downstream signaling—RAMP1—migraine	0.000514	0.00248	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—CALCRL—migraine	0.000514	0.00248	CbGpPWpGaD
Brimonidine—Musculoskeletal discomfort—Gabapentin—migraine	0.00051	0.000882	CcSEcCtD
Brimonidine—Palpitations—Topiramate—migraine	0.00051	0.000882	CcSEcCtD
Brimonidine—Loss of consciousness—Topiramate—migraine	0.000508	0.000877	CcSEcCtD
Brimonidine—Insomnia—Gabapentin—migraine	0.000507	0.000876	CcSEcCtD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000506	0.00244	CbGpPWpGaD
Brimonidine—Cough—Topiramate—migraine	0.000504	0.000871	CcSEcCtD
Brimonidine—Paraesthesia—Gabapentin—migraine	0.000503	0.000869	CcSEcCtD
Brimonidine—ADRA2A—G alpha (i) signalling events—HTR1B—migraine	0.000501	0.00242	CbGpPWpGaD
Brimonidine—AOX1—Disease—LRP1—migraine	0.000501	0.00242	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—HTR1D—migraine	0.000501	0.00242	CbGpPWpGaD
Brimonidine—Dyspnoea—Gabapentin—migraine	0.000499	0.000863	CcSEcCtD
Brimonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000499	0.00241	CbGpPWpGaD
Brimonidine—Hypertension—Topiramate—migraine	0.000499	0.000862	CcSEcCtD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000498	0.00241	CbGpPWpGaD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000498	0.00241	CbGpPWpGaD
Brimonidine—Somnolence—Gabapentin—migraine	0.000498	0.000861	CcSEcCtD
Brimonidine—Hypersensitivity—Valproic Acid—migraine	0.000498	0.00086	CcSEcCtD
Brimonidine—Dyspepsia—Gabapentin—migraine	0.000493	0.000852	CcSEcCtD
Brimonidine—Myalgia—Topiramate—migraine	0.000492	0.00085	CcSEcCtD
Brimonidine—Arthralgia—Topiramate—migraine	0.000492	0.00085	CcSEcCtD
Brimonidine—Chest pain—Topiramate—migraine	0.000492	0.00085	CcSEcCtD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000491	0.00237	CbGpPWpGaD
Brimonidine—Anxiety—Topiramate—migraine	0.00049	0.000847	CcSEcCtD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000488	0.00236	CbGpPWpGaD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000488	0.000844	CcSEcCtD
Brimonidine—Discomfort—Topiramate—migraine	0.000486	0.00084	CcSEcCtD
Brimonidine—Asthenia—Valproic Acid—migraine	0.000485	0.000838	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Gabapentin—migraine	0.000484	0.000836	CcSEcCtD
Brimonidine—Fatigue—Gabapentin—migraine	0.000483	0.000835	CcSEcCtD
Brimonidine—ADRA2A—G alpha (i) signalling events—HTR1A—migraine	0.000483	0.00233	CbGpPWpGaD
Brimonidine—Dry mouth—Topiramate—migraine	0.000481	0.000831	CcSEcCtD
Brimonidine—ADRA2C—GPCR downstream signaling—CALCRL—migraine	0.00048	0.00232	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—RAMP1—migraine	0.00048	0.00232	CbGpPWpGaD
Brimonidine—Pain—Gabapentin—migraine	0.000479	0.000828	CcSEcCtD
Brimonidine—Pruritus—Valproic Acid—migraine	0.000478	0.000826	CcSEcCtD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000475	0.0023	CbGpPWpGaD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000472	0.00228	CbGpPWpGaD
Brimonidine—Oedema—Topiramate—migraine	0.000471	0.000815	CcSEcCtD
Brimonidine—Infection—Topiramate—migraine	0.000468	0.000809	CcSEcCtD
Brimonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000466	0.00225	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—RAMP1—migraine	0.000466	0.00225	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CALCRL—migraine	0.000466	0.00225	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—HTR2B—migraine	0.000466	0.00225	CbGpPWpGaD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000465	0.00225	CbGpPWpGaD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000465	0.00225	CbGpPWpGaD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000465	0.00225	CbGpPWpGaD
Brimonidine—Shock—Topiramate—migraine	0.000464	0.000801	CcSEcCtD
Brimonidine—Nervous system disorder—Topiramate—migraine	0.000462	0.000799	CcSEcCtD
Brimonidine—Tachycardia—Topiramate—migraine	0.00046	0.000795	CcSEcCtD
Brimonidine—Skin disorder—Topiramate—migraine	0.000458	0.000791	CcSEcCtD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000456	0.0022	CbGpPWpGaD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000448	0.00216	CbGpPWpGaD
Brimonidine—Dizziness—Valproic Acid—migraine	0.000447	0.000772	CcSEcCtD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000444	0.00214	CbGpPWpGaD
Brimonidine—Hypersensitivity—Timolol—migraine	0.000443	0.000766	CcSEcCtD
Brimonidine—Hypotension—Topiramate—migraine	0.00044	0.000761	CcSEcCtD
Brimonidine—ADRA2C—Signaling by GPCR—RAMP1—migraine	0.000436	0.0021	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CALCRL—migraine	0.000436	0.0021	CbGpPWpGaD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000433	0.00209	CbGpPWpGaD
Brimonidine—Asthenia—Timolol—migraine	0.000432	0.000746	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Topiramate—migraine	0.000429	0.000742	CcSEcCtD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000428	0.00207	CbGpPWpGaD
Brimonidine—Insomnia—Topiramate—migraine	0.000426	0.000737	CcSEcCtD
Brimonidine—Rash—Valproic Acid—migraine	0.000426	0.000736	CcSEcCtD
Brimonidine—Dermatitis—Valproic Acid—migraine	0.000426	0.000736	CcSEcCtD
Brimonidine—Pruritus—Timolol—migraine	0.000426	0.000736	CcSEcCtD
Brimonidine—Headache—Valproic Acid—migraine	0.000423	0.000732	CcSEcCtD
Brimonidine—Paraesthesia—Topiramate—migraine	0.000423	0.000731	CcSEcCtD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000421	0.00203	CbGpPWpGaD
Brimonidine—Dyspnoea—Topiramate—migraine	0.00042	0.000726	CcSEcCtD
Brimonidine—Somnolence—Topiramate—migraine	0.000419	0.000724	CcSEcCtD
Brimonidine—Dyspepsia—Topiramate—migraine	0.000415	0.000717	CcSEcCtD
Brimonidine—Hypersensitivity—Gabapentin—migraine	0.000413	0.000713	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Topiramate—migraine	0.000407	0.000703	CcSEcCtD
Brimonidine—Fatigue—Topiramate—migraine	0.000406	0.000702	CcSEcCtD
Brimonidine—Pain—Topiramate—migraine	0.000403	0.000697	CcSEcCtD
Brimonidine—Asthenia—Gabapentin—migraine	0.000402	0.000695	CcSEcCtD
Brimonidine—Nausea—Valproic Acid—migraine	0.000401	0.000694	CcSEcCtD
Brimonidine—ADRA2B—GPCR ligand binding—HTR1B—migraine	0.0004	0.00193	CbGpPWpGaD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.0004	0.00193	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000399	0.00193	CbGpPWpGaD
Brimonidine—Dizziness—Timolol—migraine	0.000398	0.000688	CcSEcCtD
Brimonidine—Pruritus—Gabapentin—migraine	0.000396	0.000685	CcSEcCtD
Brimonidine—ADRA2A—GPCR downstream signaling—RAMP1—migraine	0.00039	0.00188	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—CALCRL—migraine	0.00039	0.00188	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—HTR1A—migraine	0.000385	0.00186	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000384	0.00185	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—NPS—migraine	0.000379	0.00183	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—TAC1—migraine	0.000379	0.00183	CbGpPWpGaD
Brimonidine—Rash—Timolol—migraine	0.000379	0.000656	CcSEcCtD
Brimonidine—Dermatitis—Timolol—migraine	0.000379	0.000655	CcSEcCtD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000379	0.00183	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000378	0.00183	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000378	0.00183	CbGpPWpGaD
Brimonidine—Headache—Timolol—migraine	0.000377	0.000651	CcSEcCtD
Brimonidine—ADRA2C—GPCR ligand binding—HTR1B—migraine	0.000374	0.00181	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—HTR1D—migraine	0.000373	0.0018	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—HTR2C—migraine	0.000372	0.0018	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000371	0.00179	CbGpPWpGaD
Brimonidine—Dizziness—Gabapentin—migraine	0.00037	0.00064	CcSEcCtD
Brimonidine—ADRA2B—GPCR ligand binding—EDNRA—migraine	0.000362	0.00175	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.00036	0.00174	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—HTR1A—migraine	0.00036	0.00174	CbGpPWpGaD
Brimonidine—Nausea—Timolol—migraine	0.000357	0.000618	CcSEcCtD
Brimonidine—ADRA2C—GPCR ligand binding—TAC1—migraine	0.000354	0.00171	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—NPS—migraine	0.000354	0.00171	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CALCRL—migraine	0.000354	0.00171	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—RAMP1—migraine	0.000354	0.00171	CbGpPWpGaD
Brimonidine—Rash—Gabapentin—migraine	0.000353	0.00061	CcSEcCtD
Brimonidine—Dermatitis—Gabapentin—migraine	0.000353	0.00061	CcSEcCtD
Brimonidine—Headache—Gabapentin—migraine	0.000351	0.000607	CcSEcCtD
Brimonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.00035	0.00169	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—HTR1D—migraine	0.000349	0.00168	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—CALCA—migraine	0.000348	0.00168	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—HTR2C—migraine	0.000347	0.00168	CbGpPWpGaD
Brimonidine—Hypersensitivity—Topiramate—migraine	0.000347	0.0006	CcSEcCtD
Brimonidine—ADRA2B—GPCR downstream signaling—HTR2B—migraine	0.000347	0.00168	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—HTR1D—migraine	0.000339	0.00164	CbGpPWpGaD
Brimonidine—Asthenia—Topiramate—migraine	0.000338	0.000584	CcSEcCtD
Brimonidine—ADRA2C—GPCR ligand binding—EDNRA—migraine	0.000338	0.00163	CbGpPWpGaD
Brimonidine—Pruritus—Topiramate—migraine	0.000333	0.000576	CcSEcCtD
Brimonidine—Nausea—Gabapentin—migraine	0.000333	0.000575	CcSEcCtD
Brimonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000327	0.00158	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—HTR7—migraine	0.000326	0.00157	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—CALCA—migraine	0.000325	0.00157	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000325	0.00157	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—HTR2B—migraine	0.000324	0.00157	CbGpPWpGaD
Brimonidine—AOX1—Disease—CALCA—migraine	0.000323	0.00156	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—HTR1D—migraine	0.000317	0.00153	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—HTR2B—migraine	0.000315	0.00152	CbGpPWpGaD
Brimonidine—Dizziness—Topiramate—migraine	0.000312	0.000539	CcSEcCtD
Brimonidine—ADRA2C—GPCR ligand binding—HTR7—migraine	0.000304	0.00147	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—HTR1B—migraine	0.000304	0.00147	CbGpPWpGaD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.0003	0.00145	CbGpPWpGaD
Brimonidine—Rash—Topiramate—migraine	0.000297	0.000514	CcSEcCtD
Brimonidine—Dermatitis—Topiramate—migraine	0.000297	0.000513	CcSEcCtD
Brimonidine—Headache—Topiramate—migraine	0.000295	0.00051	CcSEcCtD
Brimonidine—ADRA2C—Signaling by GPCR—HTR2B—migraine	0.000294	0.00142	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—HTR1A—migraine	0.000292	0.00141	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—NPS—migraine	0.000288	0.00139	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—TAC1—migraine	0.000288	0.00139	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—HTR1D—migraine	0.000283	0.00137	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—HTR2C—migraine	0.000282	0.00136	CbGpPWpGaD
Brimonidine—Nausea—Topiramate—migraine	0.00028	0.000484	CcSEcCtD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.00028	0.00135	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CALCRL—migraine	0.000276	0.00133	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—RAMP1—migraine	0.000276	0.00133	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—EDNRA—migraine	0.000275	0.00133	CbGpPWpGaD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000265	0.00128	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—CALCA—migraine	0.000264	0.00128	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—HTR2B—migraine	0.000263	0.00127	CbGpPWpGaD
Brimonidine—AOX1—Disease—TGFBR2—migraine	0.00026	0.00126	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—RAMP1—migraine	0.000257	0.00124	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CALCRL—migraine	0.000257	0.00124	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—HTR1D—migraine	0.000257	0.00124	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—HTR7—migraine	0.000247	0.00119	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—HTR2B—migraine	0.000239	0.00115	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CACNA1A—migraine	0.000233	0.00113	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—HTR2A—migraine	0.000228	0.0011	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000227	0.0011	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—HTR1B—migraine	0.000226	0.00109	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—HTR1A—migraine	0.000218	0.00105	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—NPS—migraine	0.000214	0.00104	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—TAC1—migraine	0.000214	0.00104	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—HTR2A—migraine	0.000213	0.00103	CbGpPWpGaD
Brimonidine—AOX1—Disease—MTHFR—migraine	0.000211	0.00102	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—HTR1B—migraine	0.000211	0.00102	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—HTR2C—migraine	0.00021	0.00102	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—RAMP1—migraine	0.000209	0.00101	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CALCRL—migraine	0.000209	0.00101	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—HTR1B—migraine	0.000205	0.000992	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—EDNRA—migraine	0.000204	0.000988	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—HTR1A—migraine	0.000203	0.000982	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—NPS—migraine	0.0002	0.000967	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—TAC1—migraine	0.0002	0.000967	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HTR1D—migraine	0.0002	0.000967	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—HTR1A—migraine	0.000198	0.000955	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—CALCA—migraine	0.000197	0.000951	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—HTR2C—migraine	0.000196	0.000948	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—TAC1—migraine	0.000195	0.00094	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—NPS—migraine	0.000195	0.00094	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—HTR1B—migraine	0.000192	0.000926	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—EDNRA—migraine	0.000191	0.000923	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—HTR2C—migraine	0.000191	0.000922	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CACNA1A—migraine	0.000189	0.000915	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HTR1D—migraine	0.000187	0.000903	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HTR2B—migraine	0.000186	0.000899	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—EDNRA—migraine	0.000186	0.000897	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—HTR1A—migraine	0.000185	0.000892	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—HTR7—migraine	0.000184	0.000889	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—CALCA—migraine	0.000184	0.000888	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—TAC1—migraine	0.000182	0.000878	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—NPS—migraine	0.000182	0.000878	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CALCA—migraine	0.000179	0.000863	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—HTR2C—migraine	0.000178	0.000861	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—MTHFR—migraine	0.000177	0.000855	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HTR2B—migraine	0.000174	0.00084	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—EDNRA—migraine	0.000173	0.000838	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—HTR2A—migraine	0.000173	0.000836	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—HTR7—migraine	0.000172	0.000831	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—HTR1B—migraine	0.000172	0.000829	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—HTR7—migraine	0.000167	0.000808	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CALCA—migraine	0.000167	0.000807	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—HTR1A—migraine	0.000165	0.000798	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—LRP1—migraine	0.000164	0.000792	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—NPS—migraine	0.000163	0.000786	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—TAC1—migraine	0.000163	0.000786	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—HTR2C—migraine	0.000159	0.00077	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—HTR7—migraine	0.000156	0.000754	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—HTR1B—migraine	0.000156	0.000753	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—EDNRA—migraine	0.000155	0.000749	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—LRP1—migraine	0.000153	0.000739	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HTR1D—migraine	0.000152	0.000734	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—HTR1A—migraine	0.00015	0.000724	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—CALCA—migraine	0.000149	0.000721	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—NPS—migraine	0.000148	0.000713	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—TAC1—migraine	0.000148	0.000713	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—HTR2C—migraine	0.000145	0.0007	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HTR2B—migraine	0.000141	0.000682	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—EDNRA—migraine	0.000141	0.000681	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—HTR7—migraine	0.00014	0.000675	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CALCA—migraine	0.000136	0.000655	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—HTR2A—migraine	0.000129	0.000623	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—HTR7—migraine	0.000127	0.000613	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NOTCH4—migraine	0.000126	0.000607	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—LRP1—migraine	0.000124	0.000601	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HTR1B—migraine	0.000121	0.000586	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—HTR2A—migraine	0.00012	0.000582	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NOTCH4—migraine	0.000117	0.000567	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—HTR2A—migraine	0.000117	0.000566	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HTR1A—migraine	0.000117	0.000564	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—TAC1—migraine	0.000115	0.000555	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NPS—migraine	0.000115	0.000555	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PGR—migraine	0.000115	0.000555	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HTR1B—migraine	0.000113	0.000547	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HTR2C—migraine	0.000113	0.000545	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—EDNRA—migraine	0.00011	0.00053	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—HTR2A—migraine	0.000109	0.000528	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HTR1A—migraine	0.000109	0.000527	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PGR—migraine	0.000107	0.000519	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NPS—migraine	0.000107	0.000519	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—TAC1—migraine	0.000107	0.000519	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NOTCH3—migraine	0.000107	0.000516	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CALCA—migraine	0.000106	0.00051	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HTR2C—migraine	0.000105	0.000509	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—EDNRA—migraine	0.000102	0.000495	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NOTCH3—migraine	9.98e-05	0.000482	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HTR7—migraine	9.88e-05	0.000477	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CALCA—migraine	9.86e-05	0.000476	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—HTR2A—migraine	9.78e-05	0.000473	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NOTCH4—migraine	9.54e-05	0.000461	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HTR7—migraine	9.23e-05	0.000446	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HTR1B—migraine	9.2e-05	0.000445	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—HTR2A—migraine	8.88e-05	0.000429	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HTR1A—migraine	8.86e-05	0.000428	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NPS—migraine	8.72e-05	0.000421	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PGR—migraine	8.72e-05	0.000421	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TAC1—migraine	8.72e-05	0.000421	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HTR2C—migraine	8.56e-05	0.000413	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—TGFBR2—migraine	8.51e-05	0.000411	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—EDNRA—migraine	8.32e-05	0.000402	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NOTCH3—migraine	8.11e-05	0.000392	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CALCA—migraine	8.01e-05	0.000387	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—TGFBR2—migraine	7.94e-05	0.000384	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—MTHFR—migraine	7.72e-05	0.000373	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HTR7—migraine	7.49e-05	0.000362	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HTR2A—migraine	6.92e-05	0.000334	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HTR2A—migraine	6.46e-05	0.000312	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TGFBR2—migraine	6.45e-05	0.000312	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—MTHFR—migraine	6.27e-05	0.000303	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—ESR1—migraine	6.14e-05	0.000297	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ESR1—migraine	5.73e-05	0.000277	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HTR2A—migraine	5.25e-05	0.000254	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ESR1—migraine	4.66e-05	0.000225	CbGpPWpGaD
